Daiwa Securities Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
184
-9,394
| -98% | -$51.1K | ﹤0.01% | 1260 |
|
|
2025
Q1 | $31K | Sell |
9,578
-343
| -3% | -$1.11K | ﹤0.01% | 1051 |
|
|
2024
Q4 | $55K | Buy |
9,921
+9,737
| +5,292% | +$54K | ﹤0.01% | 1058 |
|
|
2024
Q3 | $2K | Hold |
184
| – | – | ﹤0.01% | 1217 |
|
|
2024
Q2 | $4K | Sell |
184
-5,390
| -97% | -$117K | ﹤0.01% | 1205 |
|
|
2024
Q1 | $178K | Sell |
5,574
-298
| -5% | -$9.52K | ﹤0.01% | 1000 |
|
|
2023
Q4 | $119K | Buy |
5,872
+1,110
| +23% | +$22.5K | ﹤0.01% | 991 |
|
|
2023
Q3 | $61K | Hold |
4,762
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q2 | $86K | Buy |
4,762
+4,632
| +3,563% | +$83.7K | ﹤0.01% | 1026 |
|
|
2023
Q1 | $2K | Hold |
130
| – | – | ﹤0.01% | 1205 |
|
|
2022
Q4 | $3K | Buy |
130
+36
| +38% | +$831 | ﹤0.01% | 1185 |
|
|
2022
Q3 | $1K | Hold |
94
| – | – | ﹤0.01% | 1277 |
|
|
2022
Q2 | $1K | Hold |
94
| – | – | ﹤0.01% | 1274 |
|
|
2022
Q1 | $1K | Hold |
94
| – | – | ﹤0.01% | 1298 |
|
|
2021
Q4 | $2K | Buy |
+94
| New | +$2K | ﹤0.01% | 1273 |
|